These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6745931)

  • 1. Persistence of chromosome rearrangements in peripheral lymphocytes from patients treated with melphalan for ovarian carcinoma.
    Lambert B; Holmberg K; Einhorn N
    Hum Genet; 1984; 67(1):94-8. PubMed ID: 6745931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome damage and second malignancy in patients treated with melphalan.
    Lambert B; Holmberg K; Einhorn N
    IARC Sci Publ; 1986; (78):147-60. PubMed ID: 3583388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid tumours and chromosome aberrations as late side effects of melphalan therapy in ovarian carcinoma.
    Einhorn N; Eklund G; Lambert B
    Acta Oncol; 1988; 27(3):215-9. PubMed ID: 3415849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic findings in 111 ovarian cancer patients: therapy-related chromosome aberrations and heterochromatic variants.
    Islam MQ; Köpf I; Levan A; Granberg S; Friberg LG; Levan G
    Cancer Genet Cytogenet; 1993 Jan; 65(1):35-46. PubMed ID: 8431914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late side effects of chemotherapy in ovarian carcinoma: a cytogenetic, hematologic, and statistical study.
    Einhorn N; Eklund G; Franzén S; Lambert B; Lindsten J; Söderhäll S
    Cancer; 1982 Jun; 49(11):2234-41. PubMed ID: 7074540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal aberrations in lymphocytes of patients treated with melphalan.
    Mamuris Z; Gerbault-Seureau M; Prieur M; Pouillart P; Dutrillaux B; Aurias A
    Int J Cancer; 1989 Jan; 43(1):80-6. PubMed ID: 2910833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hprt mutations and karyotype abnormalities in T-cell clones from healthy subjects and melphalan-treated ovarian carcinoma patients.
    He SM; Holmberg K; Lambert B; Einhorn N
    Mutat Res; 1989 Feb; 210(2):353-8. PubMed ID: 2783475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spontaneous frequency of chromosomal aberrations and sister-chromatid exchanges in cultured peripheral lymphocytes of a single blood donor sampled more than 200 times.
    Andersson HC
    Mutat Res; 1993 Apr; 286(2):281-92. PubMed ID: 7681540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary.
    Dusenbery KE; Bellairs EE; Potish RA; Twiggs LB; Boente MP
    Gynecol Oncol; 2005 Feb; 96(2):307-13. PubMed ID: 15661213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic effects of low-dose radiation with different LET in human peripheral blood lymphocytes.
    Nasonova EA; Shmakova NL; Komova OV; Mel'nikova LA; Fadeeva TA; Krasavin EA; Ritter S
    Radiat Environ Biophys; 2006 Nov; 45(4):307-12. PubMed ID: 17031661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of melphalan-induced rearrangements and their transmission through cell divisions.
    Mamuris Z; Prieur M; Dutrillaux B; Aurias A
    Mutagenesis; 1989 Mar; 4(2):133-9. PubMed ID: 2659924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the levels of chromosome aberration and sister chromatid exchange induced by chemical mutagens in vitro].
    Shcheglova EG; Chebotarev AN
    Biull Eksp Biol Med; 1983 Nov; 96(11):93-5. PubMed ID: 6416331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melphalan chemotherapy in advanced ovarian carcinoma.
    Piver MS; Barlow JJ; Yazigi R; Blumenson LE
    Obstet Gynecol; 1978 Mar; 51(3):352-6. PubMed ID: 628541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chromosome aberrations induced by fortrin in human lymphocytes in cultures and in vivo].
    Sinkus AG; Sinkuvene DS
    Tsitologiia; 1976 Sep; 18(9):1115-9. PubMed ID: 1014102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis the frequency and spectrum of chromosome aberrations in irradiated in vitro peripheral blood lymphocytes of the elderly and centenarians from Kyiv.
    Talan OO; Shemetun OV; Demchenko OM; Papuga MS; Pilinska MA
    Probl Radiac Med Radiobiol; 2017 Dec; 22():231-237. PubMed ID: 29286510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant and multiaberrant (rogue) cells in peripheral lymphocytes of Hodgkin's lymphoma patients after chemotherapy.
    Ryabchenko NI; Nasonova VA; Fesenko EV; Kondrashova TV; Antoschina MM; Pavlov VV; Ryabikina NV
    Mutat Res; 2006 Oct; 601(1-2):61-70. PubMed ID: 16828123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiation-induced chromosome aberrations].
    Nefić H
    Med Arh; 2008; 62(1):4-8. PubMed ID: 18543745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adriamycin versus adriamycin plus melphalan in advanced ovarian carcinoma.
    De Palo GM; De Lena M; Bonadonna G
    Cancer Treat Rep; 1977; 61(3):355-7. PubMed ID: 326402
    [No Abstract]   [Full Text] [Related]  

  • 20. Bleomycin-induced chromosomal aberrations and sister chromatid exchanges in Down lymphocyte cultures.
    Iijima K; Morimoto K; Koizumi A; Higurashi M; Hirayama M
    Hum Genet; 1984; 66(1):57-61. PubMed ID: 6199286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.